CJC-1295 Peptide Therapy
Understanding CJC-1295
CJC-1295 is a synthetic peptide studied in scientific research as an analog of growth hormone-releasing hormone (GHRH).
Important Information
CJC-1295 is not FDA-approved and is not offered at Cienega Medical. This page is for general education only and is not medical advice.
What Is CJC-1295?
CJC-1295 is a laboratory-synthesized peptide structurally based on growth hormone-releasing hormone (GHRH). It was originally developed and studied in clinical research settings, and certain versions were investigated by pharmaceutical developers before development was discontinued. CJC-1295 is not approved by the U.S. Food and Drug Administration (FDA) for any use, and it is not an approved drug or dietary ingredient. It is classified as a research compound and is referenced in scientific literature primarily in the context of laboratory and investigational study.
FAQ
Click on a question to see more
-
What is CJC-1295?
CJC-1295 is a synthetic peptide developed as an analog of growth hormone-releasing hormone (GHRH). It has been the subject of scientific and pharmaceutical research. It is referenced in the literature as a research compound rather than as an approved medication.
-
Is CJC-1295 FDA-approved?
No. CJC-1295 is not approved by the U.S. Food and Drug Administration for any medical use. It is not an approved drug or dietary supplement ingredient and is generally categorized as a research-only compound.
-
Does Cienega Medical offer CJC-1295?
No. CJC-1295 is not offered at Cienega Medical. This page exists solely as neutral educational information.
Cared for by our 15-person Los Angeles medical team. Meet your provider →